Arcadia Biosciences, Inc.
Arcadia Biosciences, Inc. (RKDA) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
rkda · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Arcadia Biosciences, Inc. (RKDA) measures how much investors pay for each dollar of the company's trailing earnings. RKDA's current PE ratio of N/A is calculated by dividing its stock price of $0.92 by its TTM earnings per share of -$6.81.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2012 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Agricultural Inputs · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Arcadia Biosciences, Inc.You RKDA | $1M | N/A | — | -$6.81 |
 Capstone Holding Corp. CAPS | $2M | N/A | — | -$3.99 |
 CN Energy Group. Inc. CNEY | $3M | N/A | — | -$21.46 |
 Enlightify Inc. ENFY | $0M | N/A | — | $0.00 |
 Foremost Clean Energy Ltd. FMSTW | $8M | N/A | — | -$0.48 |
 Gulf Resources, Inc. GURE | $6M | N/A | — | -$54.94 |
 Inno Holdings Inc. INHD | $1M | N/A | — | -$1.31 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-1.71 | — | |
2024-12-31 FY2024 | — | $-5.16 | — | |
2023-12-31 FY2023 | — | $-11.30 | — | |
2022-12-31 FY2022 | — | $-25.65 | — | |
2021-12-31 FY2021 | — | $-27.56 | — | |
2020-12-31 FY2020 | — | $-18.70 | — | |
2019-12-31 FY2019 | — | $-181.08 | — | |
2018-12-31 FY2018 | — | $-143.16 | — | |
2017-12-31 FY2017 | — | $-291.38 | — | |
2016-12-31 FY2016 | — | $-353.85 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Arcadia Biosciences, Inc. (RKDA) measures how much investors pay for each dollar of the company's trailing earnings. RKDA's current PE ratio of N/A is calculated by dividing its stock price of $0.92 by its TTM earnings per share of -$6.81.
Frequently asked questions
RKDA pe ratio · 6 questionsRKDA's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.92 and TTM EPS of -$6.81. Data sourced from Financial Modeling Prep via RKDA's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Arcadia Biosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08